Featured
In Japan Coke is Medicine
Those who grab a Coca-Cola Plus in Japan are definitely getting something extra: a laxative and the government’s seal of approval. The Wall Street Journal reports on the unlikely sounding “health drink,” which has qualified as a “Foods for Specified Health Uses” (FOSHU) product, meaning it includes an ingredient that’s been determined by the government to bestow a health benefit. In this case, that ingredient is indigestible dextrin—5 grams of it per 16-ounce sugar- and calorie-free bottle. It’s a source of dietary fiber, and as the company explained in a February 2017 press release touting the product’s impending launch, “Drinking one Coca-Cola Plus per day with food will help suppress fat absorption and help moderate the levels of triglycerides in the blood after eating”—so long as you don’t drink too much, which could cause “loose bowels,” per a marketing VP for the company.
He says it took researchers a decade to come up with a formulation that would fall under the FOSHU umbrella but still taste good; the Journal talks to drinkers who both love it (one line of praise: “I like the feeling of the burps you get from drinking this”) and drinkers who poured it out after taking a sip. USA Today noted in May that the company doesn’t intend to bring the drink to the US, though we did have Coke Plus here once. CNBC says a vitamin- and mineral-fortified “Plus” version was released in 2007, and it fell under FDA scrutiny for not complying with a regulation that stipulates a food item bearing the word “plus” contain at least 10% more of those vitamins and minerals than its counterparts. Coca-Cola made the necessary adjustments, but the product’s run ended around 2011. (The company is offering $1 million for a new sugar substitute.)
-
Latest1 week agoPastor Chris Oyakhilome announces mother’s passing at 88 [VIDEO]
-
Latest3 days agoUS Immigration fees rise from October 16 as USCIS announces new charges
-
Football6 days agoHow David Beckham made $51.1m from 2026 World Cup, surpassing winners’ prize
-
Comments and Issues1 week agoFani-Kayode on Atiku: Separating claims from the record
-
Health6 days agoCOVID-19 Hospital care under scrutiny as US Senate hears patient, family testimonies
-
Business6 days agoOpenAI shelves GPT-6.1 astra release over safety concerns
-
Business2 days agoNigeria’s $55bn reserves raise fresh questions over naira value
-
Latest6 days agoADC’s 2027 Strategy: Who are the key players and what are their roles?


